全文获取类型
收费全文 | 206269篇 |
免费 | 28345篇 |
国内免费 | 7017篇 |
专业分类
耳鼻咽喉 | 1743篇 |
儿科学 | 1567篇 |
妇产科学 | 5153篇 |
基础医学 | 14938篇 |
口腔科学 | 2160篇 |
临床医学 | 16508篇 |
内科学 | 20565篇 |
皮肤病学 | 1366篇 |
神经病学 | 823篇 |
特种医学 | 5967篇 |
外国民族医学 | 256篇 |
外科学 | 29015篇 |
综合类 | 26415篇 |
现状与发展 | 38篇 |
一般理论 | 3篇 |
预防医学 | 9883篇 |
眼科学 | 112篇 |
药学 | 14296篇 |
137篇 | |
中国医学 | 4897篇 |
肿瘤学 | 85789篇 |
出版年
2024年 | 536篇 |
2023年 | 4225篇 |
2022年 | 8484篇 |
2021年 | 11254篇 |
2020年 | 10471篇 |
2019年 | 9491篇 |
2018年 | 9117篇 |
2017年 | 9519篇 |
2016年 | 10224篇 |
2015年 | 11863篇 |
2014年 | 17060篇 |
2013年 | 16842篇 |
2012年 | 13526篇 |
2011年 | 13708篇 |
2010年 | 9934篇 |
2009年 | 10202篇 |
2008年 | 10451篇 |
2007年 | 9763篇 |
2006年 | 8653篇 |
2005年 | 7050篇 |
2004年 | 5845篇 |
2003年 | 4847篇 |
2002年 | 4088篇 |
2001年 | 3754篇 |
2000年 | 3116篇 |
1999年 | 2654篇 |
1998年 | 2215篇 |
1997年 | 1965篇 |
1996年 | 1591篇 |
1995年 | 1502篇 |
1994年 | 1242篇 |
1993年 | 944篇 |
1992年 | 822篇 |
1991年 | 753篇 |
1990年 | 564篇 |
1989年 | 506篇 |
1988年 | 423篇 |
1987年 | 374篇 |
1986年 | 292篇 |
1985年 | 365篇 |
1984年 | 297篇 |
1983年 | 199篇 |
1982年 | 201篇 |
1981年 | 188篇 |
1980年 | 162篇 |
1979年 | 110篇 |
1978年 | 72篇 |
1977年 | 59篇 |
1976年 | 52篇 |
1975年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
971.
Nae Yu Kim Jung-Soo Pyo Dong-Wook Kang Seung-Min Yoo 《Pathology, research and practice》2019,215(3):580-585
Objective
The aim of this study was to elucidate the clinicopathological significance and prognostic role of loss of claudin-1 in colorectal cancer (CRC).Methods
The correlations between claudin-1 expression and clinicopathological characteristics, including survival rates, were assessed using immunohistochemistry on 260 archival, paraffin-embedded CRC tissues. In addition, the correlations between cludin-1 and nuclear factor-kappa B (NF-κB), epithelial-mesenchymal transition markers and tumor-infiltrating lymphocytes were investigated.Results
Claudin-1 expression was markedly lost in 42.7% of the 260 CRCs analyzed. Loss of claudin-1 expression significantly correlated with larger tumor size, vascular invasion, higher pT stage, and high metastatic lymph node ratio. In addition, loss of claudin-1 expression significantly correlated with NF-κB activation (P?<?0.001), high SNAI (P?<?0.001), and low E-cadherin (P?<?0.001) expressions. Patients with high immunoscores showed significantly lower rates of claudin-1 expression loss (P?=?0.020). In detail, loss of claudin-1 expression were frequently found in CRCs low CD3- and CD8-positive lymphocytes. There were significant correlations between claudin-1 expression loss and poor overall and recurrence-free survivals (P?<?0.001 and P?<?0.001, respectively).Conclusion
Taken together, our results suggest that the loss of claudin-1 expression significantly correlates with aggressive tumor behaviors, high SNAI expression, lower immunoscore, and poor prognoses. 相似文献972.
Bruinsma F Venn A Lancaster P Speirs A Healy D 《Human reproduction (Oxford, England)》2000,15(3):604-607
Evaluation of the long-term health of children born using in-vitro fertilization (IVF) provides important information to clinicians and consumers. Until very recently, there have been no published data on the incidence of cancer in children conceived as a result of IVF, despite a number of case reports of neuroblastoma in children conceived using fertility drugs. This study used a record-linkage cohort design to investigate the incidence of cancer in children born after IVF. The study included all conceptions using assisted reproductive technologies between 1979 and 1995 at two clinics in Victoria, Australia that resulted in a live birth. Data on births were linked with a population-based cancer registry to determine the number of cases of cancer that occurred. The standardized incidence ratio (SIR) was calculated by comparing the observed number of cases to the expected number of cases. The final cohort included 5249 births. The median length of follow-up was 3 years, 9 months (range 0-15 years). In all, 4.33 cases of cancer were expected and six were observed, giving a SIR of 1.39 (95% CI 0.62-3.09). This study found that children conceived using IVF and related procedures did not have a significantly increased incidence of cancer in comparison to the general population. 相似文献
973.
H Van Dekken E W Schervish J G Pizzolo W R Fair M R Melamed 《The Journal of pathology》1991,164(1):17-22
We have used fluorescent in situ hybridization and simultaneous in vivo bromodeoxyuridine labelling of a solid bladder cancer to examine tumour cell subsets for possible proliferative growth differences. In this dual-labelled preparation, most tumour cell nuclei exhibited monosomy 9, consistent with reported karyotypes of bladder cancer. Incorporated bromodeoxyuridine was visualized with a fluoresceinated antibody in 5-6 per cent of the tumour cells, concordant with S-phase estimates by cell cycle analysis of the flow cytometric DNA histogram. A majority of the bromodeoxyuridine-positive cells also carried the monosomy 9 chromosome abnormality. This is the first report to demonstrate the feasibility of combined in situ hybridization and detection of bromodeoxyuridine incorporated in vivo in human tumour cells in order to provide information on the growth rate of specific subsets of tumour cells identified by chromosomal constitution. 相似文献
974.
胃癌患者血清CEA、CA19—9及CA72—4联检的临床价值探讨 总被引:2,自引:1,他引:2
目的:探讨血清CEA、CA19—9及CA72—4联检在胃癌诊断、病情监测及疗效观察中的价值。方法:采用电化学发光技术检测36例正常对照组、42例良性胃病、55例胃癌患者血清CEA、CA19—9、CA72—4的含量,并对胃癌患者进行治疗前后三种肿瘤标志物的含量变化监测随防。结果:胃癌患者血清CEA、CA19—9、CA72—4的阳性率明显高于正常对照组及良性胃病组,差异有显著性(P〈0.01)。胃癌患者治疗后三种肿瘤标志物含量及阳性率较治疗前有明显下降,差异有显著性(P〈0.01)。三者联检的敏感性、准确性均显著提高(P〈0.01)。结论:血清CEA、CA19-9、CA72—4联检有助于提高胃癌诊断的敏感性、同时对疗效观察及术后监测有重要意义。 相似文献
975.
Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130 总被引:6,自引:0,他引:6
下载免费PDF全文
![点击此处可从《Genes & development》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Dannenberg JH Schuijff L Dekker M van der Valk M te Riele H 《Genes & development》2004,18(23):2952-2962
The retinoblastoma gene family consists of three genes: RB, p107, and p130. While loss of pRB causes retinoblastoma in humans and pituitary gland tumors in mice, tumorigenesis in other tissues may be suppressed by p107 and p130. To test this hypothesis, we have generated chimeric mice from embryonic stem cells carrying compound loss-of-function mutations in the Rb gene family. We found that Rb/p107- and Rb/p130-deficient mice were highly cancer prone. We conclude that in a variety of tissues tumor development by loss of pRB is suppressed by its homologs p107 and p130. The redundancy of the retinoblastoma proteins in vivo is reflected by the behavior of Rb-family-defective mouse embryonic fibroblasts in vitro. 相似文献
976.
采用免疫组化及免疫电镜技术对临床胃粘膜活检及胃癌手术标本进行了纤维连结蛋白(FN)的定位观察。结果,FN见于胃粘膜上皮细胞和部分癌细胞内以及各种基底膜、间质中。肠化及异型增生上皮细胞FN染色增强,胃癌细胞和其基膜FN减少缺失且与癌细胞分化程度相关,胃癌间质FN丰富,尤其以癌浸润前缘明显。本文着重讨论了胃癌FN改变与癌细胞生物学特性的关系。 相似文献
977.
Aasmund Berner Gry Geitvik Frank Karlsen Sophie D. Foss Jahn M. Nesland Anne-Lise B
Rresen 《The Journal of pathology》1995,176(3):299-308
The TP53 gene mutation pattern in prostatic cancer was examined in relation to progression and survival, using archival formalin-fixed pre-and post-treatment tumour specimens from 84 prostatic cancer patients. Thirty-four had hormone-sensitive tumours and 50 were hormone-resistant. Six of the 34 (18 per cent) therapy-responding tumours and 19 of the 50 (38 per cent) hormone-resistant tumours showed p53 protein accumulation in the post-treatment specimen. Both pre- and post-treatment specimens from these 25 patients were analysed for mutation of the conserved regions of the TP53 gene (exons 5–8), using constant denaturant gel electrophoresis (CDGE) followed by DNA sequencing. In the post-treatment samples, mutations were detected in three of the six patients with hormone-responsive tumours and in 11 of the 19 patients with hormone-resistant tumours. The three (100 per cent) patients with therapy-responsive tumours with mutations and nine of the 11 (82 per cent) patients with therapy-resistant tumours with mutations died of the disease. Thirteen of the 14 mutations in the post-treatment specimens were transitions, 11 occurring at CpG dinucleotides in which codon 273 was involved in ten. A significantly higher proportion of tumours with mutations were poorly differentiated compared with tumours without mutation (P<0·04). Our findings indicate that TP53 mutation is a late event in tumour development of the prostate gland and that codon 273 might be a ‘hotspot’ for mutation in the progression of the disease. 相似文献
978.
Fernando Carlos Schmitt Maria Jos Bento Isabel Amendoeira 《Diagnostic cytopathology》1995,13(4):347-351
We describe a method of immunocytochemically assessing estrogen receptor (ER) status on alcohol-fixed smears obtained by fine-needle aspiration (FNA) from breast cancer patients, using a commercially available monoclonal antibody (1D5) with microwave oven processing. A series of 31 cases of aspirates from breast cancer were analysed and the results were compared with assessment by ER immunocytochemical assay using the same procedure on formalin-fixed tissue and with assessment by ER-ICA assay on frozen sections. The results were scored semiquantitatively using a five grade scoring system. Of the 31 cases examined, 21 were positive at least by two methods and 10 were negative for all three determinations. The results obtained in the ER immunocytochemical assay on aspirates and paraffin-sections using the antibody 1D5 and those obtained on frozen sections using the antibody H222 were closely similar. In only one case was it not possible to interpret the reaction in the cytological specimen because there was a strong background in the smear. In general, we obtained more intense positivity with the antibody 1D5 in aspirates and formalin-fixed material than with the antibody H222 in frozen sections. The scoring results of the three methods were almost identical. We conclude that the application of ER method on alcohol-fixed smears will eliminate the need for using a special fixation procedure and will provide several advantages, such as: improvement in morphological concomitant analysis, utilization whenever malignancy is found without necessity to re-aspirate the patient, and adequacy of archival material. © 1995 Wiley-Liss, Inc. 相似文献
979.
Efficient genetic analysis of large exonic regions containing heterozygous mutations and common polymorphisms can be difficult. We have analyzed 30 patients for inherited susceptibility mutations (ISM) within exon 11 of the BRCA1 gene as part of an ongoing genetic epidemiological study of high-risk breast cancer (HRBC). A novel combination of restriction endonuclease fingerprinting (REF) and conformation sensitive gel electrophoresis (CSGE) was developed for rapid and efficient screening of mutations. This method (REF-CSGE) was compared side-by-side with standard CSGE and evaluated for both efficiency and sensitivity of detection. REF-CSGE detected 100% of the alterations found by CSGE. However, one variant was only detectable by REF-CSGE. All samples with variant bands were sequenced to confirm the nature of the alteration. In total, two small deletions (frameshifts) and 62 point mutations (60 known polymorphisms and two variants of unknown significance) were found in our cohort. The majority of the exon 11 polymorphisms detected are inherited as a linked haplotype. Point mutations that comprise these haplotypes could be simultaneously detected on a single gel by REF-CSGE, thereby decreasing the number of sequencing reactions necessary to elucidate heteroduplex patterns seen on CSGE gels. An analysis of the overall efficiency of both techniques revealed that REF-CSGE required 67% fewer confirmatory sequencing reactions, resulting in savings in both reagents and technician time. 相似文献
980.
Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma – diagnostic and prognostic implications 总被引:2,自引:0,他引:2
Berner HS Davidson B Berner A Risberg B Kristensen GB Trope CG Van de Putte G Nesland JM 《Clinical & experimental metastasis》2000,18(2):197-202
CD44 is a family of cell adhesion molecules involved in a variety of cellular functions. The present study analysed the expression
of two CD44 isoforms in serous effusions of patients diagnosed with ovarian carcinoma and corresponding primary and metastatic
lesions. Fifty-eight effusions, 23 primary ovarian tumours, and 44 metastatic lesions were studied for protein expression
of CD44s and v3-10 using immunohistochemistry. Results were correlated with clinical parameters. CD44v3-10 was seen in carcinoma
cells in the majority of cases at all sites. Malignant effusions showed an up-regulation of CD44s compared to both primary
tumours and metastatic solid lesions. Mesothelial cells frequently expressed CD44s, but were rarely immunoreactive for v3-10.
CD44s immunoreactivity in cancer cells in effusions was significantly more often observed in patients with FIGO stage 3 than
in stage 4 patients (P = 0.045). Staining results did not correlate with age, effusion site, metastatic site, tumour grade or residual tumour mass
after initial surgery. Likewise, comparison of overall and disease-free survival with expression of the CD44 isoforms studied
did not reveal any statistically significant associations. The up-regulation in CD44 levels in effusions, primarily in stage
3 disease, suggests that adhesion of ovarian carcinoma cells to mesothelium may be regulated at the level of CD44s expression,
and provides further evidence of phenotypic alteration in the transition from primary tumour cell clones to effusions. The
similar expression profile of CD44 in carcinoma cells in peritoneal and pleural effusions supports our previous observations
and the hypothesis that carcinoma cells in peritoneal effusions are truly metastatic.
This revised version was published online in July 2006 with corrections to the Cover Date. 相似文献